Manufacturing and Optimization the Nanofibres Tissue of Poly(Nvinyl-2-pyrrolidone) - Poly(e-caprolactone) Shell/Poly(N-vinyl-2-pyrrolidone) -Amphotericin B Core for Controlled Drug Release System
Vol. 19, No. 3, pp. 620-626, Mar. 2018
10.1007/s12221-018-7496-x
-
Coaxial nanofibers Biodegradability Working distance Controlled drug release Poly(e-caprolactone) Poly(N-vinyl-2-pyrrolidone)
Abstract
Statistics
Cumulative Counts from November, 2022
Multiple requests among the same browser session are counted as one view. If you mouse over a chart, the values of data points will be shown.
Multiple requests among the same browser session are counted as one view. If you mouse over a chart, the values of data points will be shown.
|
Cite this article
[IEEE Style]
F. R. V. a. D. Semnani, "Manufacturing and Optimization the Nanofibres Tissue of Poly(Nvinyl-2-pyrrolidone) - Poly(e-caprolactone) Shell/Poly(N-vinyl-2-pyrrolidone) -Amphotericin B Core for Controlled Drug Release System," Fibers and Polymers, vol. 19, no. 3, pp. 620-626, 2018. DOI: 10.1007/s12221-018-7496-x.
[ACM Style]
Fataneh Rouhollahi Vernosfaderani and Dariush Semnani. 2018. Manufacturing and Optimization the Nanofibres Tissue of Poly(Nvinyl-2-pyrrolidone) - Poly(e-caprolactone) Shell/Poly(N-vinyl-2-pyrrolidone) -Amphotericin B Core for Controlled Drug Release System. Fibers and Polymers, 19, 3, (2018), 620-626. DOI: 10.1007/s12221-018-7496-x.